. . . . . . . "[This Commentary provides a context for the use of efficacy pipeline pharmacogenetics (PGx) in therapeutic programs.Jordan et al. published the results of an obesity trial with a cholecystokinin-A (CCK-A) receptor agonist and concluded that CCK-A by itself does not have a central role in long-term energy balance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:16+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .